In tofacitinib-treated patients with RA and a history of atherosclerotic CVD, occurrence of MACE is lower with statin use; tofacitinib users on statins have similar MACE rates to TNF-inhibitor users.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/statin-use-may-mitigate-major-cardiovascular-event-risk-2025a1000rho?src=rss
Author :
Publish date : 2025-10-13 10:10:00
Copyright for syndicated content belongs to the linked Source.